0000874015-15-000062.txt : 20150702 0000874015-15-000062.hdr.sgml : 20150702 20150702175842 ACCESSION NUMBER: 0000874015-15-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150702 DATE AS OF CHANGE: 20150702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 15971330 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-07-01 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001206369 KLEIN JOSEPH III C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2015-07-01 2015-07-01 4 M 0 469 0 A 4564 D Common Stock 2015-07-01 2015-07-01 4 M 0 667 0 A 5231 D Common Stock 2015-07-02 2015-07-02 4 M 0 312 0 A 5543 D Common Stock 100 I By Son Restricted Stock Units 2015-07-01 2015-07-01 4 M 0 469 0 D Common Stock 469 937 D Restricted Stock Units 2015-07-01 2015-07-01 4 M 0 667 0 D Common Stock 667 2000 D Restricted Stock Units 2015-07-02 2015-07-02 4 M 0 312 0 D Common Stock 312 312 D Restricted Stock Units 2015-07-01 2015-07-01 4 A 0 2667 0 A Common Stock 2667 2667 D Director Stock Option (right to buy) 57.16 2015-07-01 2015-07-01 4 A 0 16000 0 A 2016-07-01 2025-06-30 Common Stock 16000 16000 D Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on July 1, 2013. Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on July 1, 2014. Acquired pursuant to vesting and release of shares pursuant to an RSU award granted on July 2, 2012. Each Restricted Stock Unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value. Restricted Stock Unit Award granted on July 1, 2013. Restricted Stock Units vest in equal annual installments, the first installment vested on July 1, 2014. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2017. Restricted Stock Unit Award granted on July 1, 2014. Restricted Stock Units vest in equal annual installments, the first installment vested on July 1, 2015. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2018. Restricted Stock Unit Award granted on July 2, 2012. Restricted Stock Units vest in equal annual installments, the first installment vested on July 2, 2013. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 2, 2016. Grant of July 1, 2015 to reporting person of Restricted Stock Unit Award under the Isis Pharmacueticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2016. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2019. The RSU is vested as to 0 shares on July 1, 2015. Grant of July 1, 2015 to reporting person of stock options under the Isis Pharmacueticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2016. The option shall be fully vested and exercisable on July 1, 2019. The stock option was exercisable as to 0 shares on July 1, 2015. /s/B. Lynne Parshall, attorney-in-fact 2015-07-02